744 related articles for article (PubMed ID: 30619286)
1. Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.
Ma Q; Long W; Xing C; Chu J; Luo M; Wang HY; Liu Q; Wang RF
Front Immunol; 2018; 9():2924. PubMed ID: 30619286
[TBL] [Abstract][Full Text] [Related]
2. Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.
Zhu X; Fang Y; Chen Y; Chen Y; Hong W; Wei W; Tu J
Life Sci; 2023 May; 320():121558. PubMed ID: 36889666
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
Zhai Y; Li G; Li R; Chang Y; Feng Y; Wang D; Wu F; Zhang W
Front Immunol; 2020; 11():581209. PubMed ID: 33133100
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of glioma stem cell-mediated immune tolerance in tumor microenvironment].
Xie T; Ma JW; Liu B; Dong J; Huang Q
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):808-813. PubMed ID: 29151286
[No Abstract] [Full Text] [Related]
6. T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.
Mondal S; Hazra I; Datta A; Sk Md OF; Moitra S; Tripathi SK; Chaudhuri S
J Cell Physiol; 2018 Jan; 233(1):269-290. PubMed ID: 28233371
[TBL] [Abstract][Full Text] [Related]
7. Glioma stem cells and their roles within the hypoxic tumor microenvironment.
Boyd NH; Tran AN; Bernstock JD; Etminan T; Jones AB; Gillespie GY; Friedman GK; Hjelmeland AB
Theranostics; 2021; 11(2):665-683. PubMed ID: 33391498
[TBL] [Abstract][Full Text] [Related]
8. Glioma escape signature and clonal development under immune pressure.
Maire CL; Mohme M; Bockmayr M; Fita KD; Riecken K; Börnigen D; Alawi M; Failla A; Kolbe K; Zapf S; Holz M; Neumann K; Dührsen L; Lange T; Fehse B; Westphal M; Lamszus K
J Clin Invest; 2020 Oct; 130(10):5257-5271. PubMed ID: 32603315
[TBL] [Abstract][Full Text] [Related]
9. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment.
Mi Y; Guo N; Luan J; Cheng J; Hu Z; Jiang P; Jin W; Gao X
Front Immunol; 2020; 11():737. PubMed ID: 32391020
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
12. Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol.
Fei X; Wang A; Wang D; Meng X; Ma J; Hong L; Qin R; Wang A; Dong J; Huang Q; Wang Z
BMC Immunol; 2018 Feb; 19(1):7. PubMed ID: 29390972
[TBL] [Abstract][Full Text] [Related]
13. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology and immunotherapeutic targeting of glioma stem cells.
Madany M; Thomas TM; Edwards L; Yu JS
Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
[TBL] [Abstract][Full Text] [Related]
16. Microglia in the Brain Tumor Microenvironment.
Cole AP; Hoffmeyer E; Chetty SL; Cruz-Cruz J; Hamrick F; Youssef O; Cheshier S; Mitra SS
Adv Exp Med Biol; 2020; 1273():197-208. PubMed ID: 33119883
[TBL] [Abstract][Full Text] [Related]
17. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
18. Glioma stem cells reconstruct similar immunoinflammatory microenvironment in different transplant sites and induce malignant transformation of tumor microenvironment cells.
Xie T; Liu B; Dai CG; Lu ZH; Dong J; Huang Q
J Cancer Res Clin Oncol; 2019 Feb; 145(2):321-328. PubMed ID: 30415302
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
20. Glioma stem cell research for the development of immunotherapy.
Xu Q; Yuan X; Yu JS
Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]